Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
They are going have cash lockdown until May. In the interim find out what the problem is. That determines how much and at what price. Small prob small raise, big prob, big raise. That’s the total message of the RNS. We’ve renegotiated the loan terms to buy us time to plan the above and Hercules have been very reasonable It’s not rocket science
i'm not offended, jay, i'm just surprised at how you're trying to split hairs. if an rns makes any, any, any mention of the need for further cash, then it's a placing... it has to be as, for the third time, they're not going to get a loan to pay off a loan... if they did that then they might as well go to hercules... that'd be funny!
the only way there's no placing is if they say 'oopsie, fda got it wrong and all's good for april'... which they can't possibly say. as there's no indicator of how long it'll take to get to even talk to fda, never mind produce further content, this needs funding into end of Q3, at worst... but no better than beggining... all imo. but i don't see any way around it, without jeopardising the co's existence.
not trolling, just making some more realistic assumptions than 'back to 20p by teatime'. that was possible before invesco dumped rns on thurs but not now without something that says fda is 'merely an admin incident' and not more.
A raise at 5p doesn’t mean it won’t go to 20p+ in the short term once the uncertainty of said placing has been removed. I would make it a bit difficult for AMP to brake even though, unless they somehow managed to partake.
marineville isn't this exactly what the company will be doing in the conference call.
ps. i'm not trying to pee on anyone's chips here... i still hold some shares... but i think a bit of realism about how this goes forward is required here... and it wouldn't hurt for the co to state their intentions and where they think the errors lie... that would certianly give confidence to the s/h.
jay, think you're playing silly buggers re. the rns... if you'd like to explain what other options they'd have, i'd be willing to contemplate that... but, as i said, they're not going to take out a loan at more onerous terms to pay off a loan.
if you think a company blithely states they 'might' do a placing then they'll do a placing. once it's in the public domain it affects the sp... the only question now is how high can the sp rise under the current conditions and at what point will they make the placing and to whom and under what terms.
today's rns kinda helped... except it didn't...
gla.
i read further... can't see what you're getting at?
Read it further
The great thing about this bb is that literally no posts effect the DMAs
"Following the $7 million repayment, Motif Bio will have cash of approximately $3 million and $7.7 million of outstanding debt drawn from the Hercules loan facility. Following this amendment, the Company intends to manage the funds available to it aggressively and will need to raise capital in the near term."
unlikey to come from another loan, to pay off a loan, now is it?